Asklepion Pharmaceuticals
2006
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Corporate
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Operator of a pharmaceutical company engaged in the research and development. The company mainly focuses on different types of liver-based diseases.
Website
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Services
Primary Office
- 729 East Pratt Street
- Suite 360
- Baltimore, MD 21202
- United States
+1 (410) 000-0000
Asklepion Pharmaceuticals Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Asklepion Pharmaceuticals‘s full profile, request access.
Request full access to PitchBookAsklepion Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Asklepion Pharmaceuticals‘s full profile, request access.
Request full access to PitchBookAsklepion Pharmaceuticals Executive Team (4)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Gary Pasternack Ph.D | Chief Executive Officer | ||
| Kenneth Setchell Ph.D | Chief Scientific Officer | ||
| Gary Pyner Sr. | Chief Commercial Officer |
1 Former Executive
You’re viewing 3 of 4 executives. Get the full list »